<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35303908</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1750-1172</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>17</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Orphanet journal of rare diseases</Title>
          <ISOAbbreviation>Orphanet J Rare Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Coexistence of craniopharyngioma and cranial fibrous dysplasia: a case series of clinicopathological study.</ArticleTitle>
        <Pagination>
          <StartPage>126</StartPage>
          <MedlinePgn>126</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">126</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13023-022-02281-1</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Craniopharyngioma (CP) and cranial fibrous dysplasia (CFD) are rare embryonic benign cranial diseases that most commonly present during childhood or adolescence. The coexistence of CP and CFD is extremely rare and has not yet been reported.</AbstractText>
          <AbstractText Label="METHODS">We retrospectively reviewed the data of five patients with concomitant CP and CFD treated at Beijing Tiantan Hospital from January 2003 to January 2021 and summarized their clinicopathological features, treatment modalities, and outcomes. We also performed a comprehensive literature review, tested the patients for characteristic GNAS gene mutations related to CFD, and tested the CP specimens for corresponding Gsα protein to explore the potential connection leading to the coexistence of CP and CFD.</AbstractText>
          <AbstractText Label="RESULTS">The cohort comprised four men and one woman (median age, 39 years). The symptoms mainly included headache, dizziness, fatigue, polyuria/polydipsia, hypogonadism, and blurred vision. CFD most commonly involved the sphenoid bone (n = 4). Four patients underwent surgery to remove the CP (one trans-sphenoidal and three transcranial resections); complete and subtotal resection were achieved in two patients, respectively. The tumor subtype was adamantinomatous in three patients and unknown in one. The common postoperative complications were panhypopituitarism, diabetes insipidus, and hypothyroidism. The mean follow-up duration was 57.2 months. Two patients required postoperative hormone replacement therapy. Three patients underwent genetic study of the tumor specimens; GNAS mutations were not detected, but these patients were positive for Gsα protein.</AbstractText>
          <AbstractText Label="CONCLUSIONS">Although a definite causative relationship has not been proved, the coexistence of CP and CFD means that potential interplay or an atypical fibrous dysplasia course as uncommon manifestations of CP cannot be excluded. It is more challenging to initiate prompt diagnosis and appropriate treatment for concomitant CP and CFD than for solitary CP because of skull base deformations. Current management strategies are aimed at surgical treating the CP and regularly monitoring the CFD.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fan</LastName>
            <ForeName>Yang-Hua</ForeName>
            <Initials>YH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No.119, the South Fourth Ring West Road, Fengtai District, Beijing, 100070, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Zhi</ForeName>
            <Initials>Z</Initials>
            <Identifier Source="ORCID">0000-0002-3253-0829</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No.119, the South Fourth Ring West Road, Fengtai District, Beijing, 100070, China. lzsjwk@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Orphanet J Rare Dis</MedlineTA>
        <NlmUniqueID>101266602</NlmUniqueID>
        <ISSNLinking>1750-1172</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003397" MajorTopicYN="Y">Craniopharyngioma</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005357" MajorTopicYN="Y">Fibrous Dysplasia of Bone</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010911" MajorTopicYN="Y">Pituitary Neoplasms</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012886" MajorTopicYN="N">Skull</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Clinicopathologic features</Keyword>
        <Keyword MajorTopicYN="Y">Coexistence</Keyword>
        <Keyword MajorTopicYN="Y">Cranial fibrous dysplasia</Keyword>
        <Keyword MajorTopicYN="Y">Craniopharyngioma</Keyword>
        <Keyword MajorTopicYN="Y">Treatment</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>19</Day>
          <Hour>5</Hour>
          <Minute>26</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35303908</ArticleId>
        <ArticleId IdType="pmc">PMC8932149</ArticleId>
        <ArticleId IdType="doi">10.1186/s13023-022-02281-1</ArticleId>
        <ArticleId IdType="pii">10.1186/s13023-022-02281-1</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Martinez-Barbera JP, Andoniadou CL. Biological behaviour of craniopharyngiomas. Neuroendocrinology. 2020;110(9–10):797–804. doi: 10.1159/000506904.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000506904</ArticleId>
            <ArticleId IdType="pubmed">32126562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg. 1998;89(4):547–551. doi: 10.3171/jns.1998.89.4.0547.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3171/jns.1998.89.4.0547</ArticleId>
            <ArticleId IdType="pubmed">9761047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sekine S, Shibata T, Kokubu A, Morishita Y, Noguchi M, Nakanishi Y, Sakamoto M, Hirohashi S. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol. 2002;161(6):1997–2001. doi: 10.1016/S0002-9440(10)64477-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0002-9440(10)64477-X</ArticleId>
            <ArticleId IdType="pmc">PMC1850925</ArticleId>
            <ArticleId IdType="pubmed">12466115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, Lawrence MS, Rodriguez FJ, Bernardo LA, Schubert L, Sunkavalli A, Shillingford N, Calicchio ML, Lidov HG, Taha H, Martinez-Lage M, Santi M, Storm PB, Lee JY, Palmer JN, Adappa ND, Scott RM, Dunn IF, Laws ER, Jr, Stewart C, Ligon KL, Hoang MP, Van Hummelen P, Hahn WC, Louis DN, Resnick AC, Kieran MW, Getz G, Santagata S. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014;46(2):161–165. doi: 10.1038/ng.2868.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng.2868</ArticleId>
            <ArticleId IdType="pmc">PMC3982316</ArticleId>
            <ArticleId IdType="pubmed">24413733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weinstein LS. G(s)alpha mutations in fibrous dysplasia and McCune-Albright syndrome. J Bone Miner Res. 2006;21(Suppl 2):P120–P124. doi: 10.1359/jbmr.06s223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1359/jbmr.06s223</ArticleId>
            <ArticleId IdType="pubmed">17229000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diah E, Morris DE, Lo LJ, Chen YR. Cyst degeneration in craniofacial fibrous dysplasia: clinical presentation and management. J Neurosurg. 2007;107(3):504–508. doi: 10.3171/JNS-07/09/0504.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3171/JNS-07/09/0504</ArticleId>
            <ArticleId IdType="pubmed">17886547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riminucci M, Liu B, Corsi A, Shenker A, Spiegel AM, Robey PG, Bianco P. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks. J Pathol. 1999;187(2):249–258. doi: 10.1002/(SICI)1096-9896(199901)187:2&lt;249::AID-PATH222&gt;3.0.CO;2-J.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1096-9896(199901)187:2&lt;249::AID-PATH222&gt;3.0.CO;2-J</ArticleId>
            <ArticleId IdType="pubmed">10365102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tafti D, Cecava ND, Fibrous Dysplasia, StatPearls, Treasure Island (FL), 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Maiuri F, Cappabianca P, Iaconetta G, Esposito F, Messina A. Simultaneous presentation of meningiomas with other intracranial tumours. Br J Neurosurg. 2005;19(4):368–375. doi: 10.1080/02688690500305548.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/02688690500305548</ArticleId>
            <ArticleId IdType="pubmed">16455550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh DK, Singh N, Parihar A, Singh R. Craniopharyngioma and epidermoid tumour in same child: a rare association, BMJ Case Rep 2013 (2013).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3703010</ArticleId>
            <ArticleId IdType="pubmed">23737578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takei H, Powell SZ. Tumor-to-tumor metastasis to the central nervous system. Neuropathology. 2009;29(3):303–308. doi: 10.1111/j.1440-1789.2008.00952.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1440-1789.2008.00952.x</ArticleId>
            <ArticleId IdType="pubmed">18647266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amit A, Achawal S, Dorward N. Pituitary macro adenoma and vestibular schwannoma: a case report of dual intracranial pathologies. Br J Neurosurg. 2008;22(5):695–696. doi: 10.1080/02688690801987366.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/02688690801987366</ArticleId>
            <ArticleId IdType="pubmed">18661423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hasegawa H, Jentoft ME, Young WF, Jr, Lakomkin N, Van Gompel JJ, Link MJ, Atkinson JL, Meyer FB. Collision of Craniopharyngioma and pituitary adenoma: comprehensive review of an extremely rare Sellar condition. World Neurosurg. 2021;149:e51–e62. doi: 10.1016/j.wneu.2021.02.091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.wneu.2021.02.091</ArticleId>
            <ArticleId IdType="pubmed">33647491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu G, Su L, Xiang Y, Liu Y, Zhang S. Coexistence of craniopharyngioma and meningioma: two rare cases and literature review. Medicine (Baltimore) 2020;99(50):e23183. doi: 10.1097/MD.0000000000023183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000023183</ArticleId>
            <ArticleId IdType="pmc">PMC7738034</ArticleId>
            <ArticleId IdType="pubmed">33327235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pekmezci M, Louie J, Gupta N, Bloomer MM, Tihan T. Clinicopathological characteristics of adamantinomatous and papillary craniopharyngiomas: University of California, San Francisco experience 1985–2005. Neurosurgery. 2010;67(5):1341–9. doi: 10.1227/NEU.0b013e3181f2b583.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1227/NEU.0b013e3181f2b583</ArticleId>
            <ArticleId IdType="pubmed">20871436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghosal N, Furtado SV, Santosh V, Sridhar M, Hegde AS. Co-existing fibrous dysplasia and atypical lymphoplasmacyte-rich meningioma. Neuropathology. 2007;27(3):269–272. doi: 10.1111/j.1440-1789.2007.00753.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1440-1789.2007.00753.x</ArticleId>
            <ArticleId IdType="pubmed">17645241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tasar M, Ors F, Yetiser S, Ugurel MS, Ucoz T. Multiple globoid meningiomas associated with craniomandibular fibrous dysplasia: case report. Clin Imaging. 2004;28(1):20–22. doi: 10.1016/S0899-7071(03)00008-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0899-7071(03)00008-1</ArticleId>
            <ArticleId IdType="pubmed">14996442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shenker A, Weinstein LS, Moran A, Pescovitz OH, Charest NJ, Boney CM, Van Wyk JJ, Merino MJ, Feuillan PP, Spiegel AM. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr. 1993;123(4):509–518. doi: 10.1016/S0022-3476(05)80943-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0022-3476(05)80943-6</ArticleId>
            <ArticleId IdType="pubmed">8410501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spencer T, Pan KS, Collins MT, Boyce AM. The Clinical SPECTRUM of McCune–Albright syndrome and its management. Horm Res Paediatr. 2019;92(6):347–356. doi: 10.1159/000504802.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000504802</ArticleId>
            <ArticleId IdType="pmc">PMC7302983</ArticleId>
            <ArticleId IdType="pubmed">31865341</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robinson C, Estrada A, Zaheer A, Singh VK, Wolfgang CL, Goggins MG, Hruban RH, Wood LD, Noe M, Montgomery EA, Guthrie LC, Lennon AM, Boyce AM, Collins MT. Clinical and radiographic gastrointestinal abnormalities in McCune-Albright syndrome. J Clin Endocrinol Metab. 2018;103(11):4293–4303. doi: 10.1210/jc.2018-01022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2018-01022</ArticleId>
            <ArticleId IdType="pmc">PMC6194803</ArticleId>
            <ArticleId IdType="pubmed">30124968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Majoor BC, Boyce AM, Bovee JV, Smit VT, Collins MT, Cleton-Jansen AM, Dekkers OM, Hamdy NA, Dijkstra PS, Appelman-Dijkstra NM. Increased risk of breast cancer at a young age in women with fibrous dysplasia. J Bone Miner Res. 2018;33(1):84–90. doi: 10.1002/jbmr.3286.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jbmr.3286</ArticleId>
            <ArticleId IdType="pubmed">28856726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Florenzano P, Pan KS, Brown SM, Paul SM, Kushner H, Guthrie LC, de Castro LF, Collins MT, Boyce AM. Age-related changes and effects of bisphosphonates on bone turnover and disease progression in fibrous dysplasia of bone. J Bone Miner Res. 2019;34(4):653–660. doi: 10.1002/jbmr.3649.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jbmr.3649</ArticleId>
            <ArticleId IdType="pmc">PMC6983318</ArticleId>
            <ArticleId IdType="pubmed">30645769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zada G, Lin N, Ojerholm E, Ramkissoon S, Laws ER. Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships. Neurosurg Focus. 2010;28(4):E4. doi: 10.3171/2010.2.FOCUS09318.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3171/2010.2.FOCUS09318</ArticleId>
            <ArticleId IdType="pubmed">20367361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jensterle M, Jazbinsek S, Bosnjak R, Popovic M, Zaletel LZ, Vesnaver TV, Kotnik BF, Kotnik P. Advances in the management of craniopharyngioma in children and adults. Radiol Oncol. 2019;53(4):388–396. doi: 10.2478/raon-2019-0036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2478/raon-2019-0036</ArticleId>
            <ArticleId IdType="pmc">PMC6884937</ArticleId>
            <ArticleId IdType="pubmed">31652121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee JS, FitzGibbon EJ, Chen YR, Kim HJ, Lustig LR, Akintoye SO, Collins MT, Kaban LB. Clinical guidelines for the management of craniofacial fibrous dysplasia. Orphanet J Rare Dis. 2012;7(Suppl 1):S2. doi: 10.1186/1750-1172-7-S1-S2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1750-1172-7-S1-S2</ArticleId>
            <ArticleId IdType="pmc">PMC3359960</ArticleId>
            <ArticleId IdType="pubmed">22640797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Z, Wang Z, Qian H. Malignant transformation of craniofacial fibrous dysplasia: a systematic review of overall survival. Neurosurg Rev. 2020;43(3):911–921. doi: 10.1007/s10143-019-01089-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10143-019-01089-1</ArticleId>
            <ArticleId IdType="pubmed">30809751</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
